Manifestaciones digestivas de la infección por SARS-COV-2
DOI:
https://doi.org/10.66737/ier.zub.280Keywords:
SARS-CoV-2, COVID-19, Digestive System, Liver, Endoscopy, Inflammatory Bowel DiseaseAbstract
The pandemic caused by SARS-CoV-2 has led to a global health crisis. It has been a challenge for the health system. Although it primarily affects respiratory system, other organs such as the digestive tract can be affected. Many studies have shown that COVID-19 elevates liver enzymes and causes abdominal pain, nausea and diarrhea. Furthermore, the pandemic has forced to reorganize endoscopy services because of the risk of virus transmission during endoscopies. In this article we review the relationship between COVID-19 and the digestive system.
Downloads
References
Alloca M, Chaparro M, Gonzalez HA, Bosca-Watts MM, Palmela C, D’Amico F, et al., (2020). Patients with Inflammatory Bowel Disease Are not at Increased Risk of COVID-19: A Large Multinational Cohort Study. Journal of Clinical Medicine, 9:3533.
Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, et al., (2020). Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Reports, 2:100169.
Brenner EJ, Ungaro RC, Gearry R, Kaplan G, Kissous-Hunt M, Lewis J, et al., (2020). Corticoids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology, 159:481-91.
Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al., (2020). COVID-19: Abnormal liver function tests. Journal of Hepatology, 73:566-74.
Cárdenas-Jaén, K, Sánchez-Luna, SA et al., (2020). Gastrointestinal Symptoms and complications of COVID-19: an international multicenter prospective cohort study (TIVURON PROJECT). UEG Journal, 8(10): 1273.
Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, et al., (2021). Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patient. Journal of Hepatology, 74:148–55.
Dandan Tian MS, Quing Ye MD. (2020). Hepatic complications of COVID-19 and its treatment. Journal of Medical Virology, 92:1818-24.
Hayashi Y, Wagatsuma K, Nojima M, Yamakawa T, Ichimiya T, Yokoyama Y, et al., (2021). The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis. Journal of Gastroenterology, 56:409-20.
Magro F, Rahier JF, Abreu C, MacMahon E, Hart A, van der Woude CJ, et al., (2020). Inflammatory bowel disease management during the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce. Journal of Crohn’s Colitis, 14, Suppl 3:S798–S806.
Marín-Gabriel JC, Rodríguez de Santiago E. (2020). Documento de posicionamiento AEG-SEED para el reinicio de la actividad endoscópica tras la fase pico de la pandemia de COVID-19. Gastroenterología y Hepatología, 33:389-407.
Monteoleone G, Ardizzone S. (2020). Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? Journal of Crohn’s & Colitis, 14:1334-6.
Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T, et al., (2020). Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with Coronavirus disease 2019: a systematic review and meta-analysis. JAMA, 3:e2011335.
Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. (2020). Hepatic consequences of COVID-19 infection. Lapping or biting? European Journal of Internal Medicine, 77:18–24.
Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey Enrique. (2020). 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics, 52: 276-83.
Tellez L, Martín Mateos RM. (2020). Actualización en COVID-19 y enfermedad hepática. Gastroenterology and Hepatology, 43:472-80.
Wang W, Xu Y, Gao R, et al., (2020). Detection of SARS-CoV-2 in different types of clinical specimens. JAMA, 323:1843-4.
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L. (2020). SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. Journal of Hepatology, 73:807-16.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 María Calvo Íñiguez, Berta Lapeña Muñoz (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en Zubía conservan los derechos de autor de sus trabajos y autorizan a la revista la primera publicación de los mismos.
Los artículos se publican bajo la licencia Creative Commons Atribución–No Comercial–Compartir Igual (CC BY-NC-SA), que permite su uso, distribución y reproducción en cualquier medio, siempre que se cite adecuadamente la autoría original, no se realice un uso comercial y se mantenga la misma licencia.
